MAPKAPK3

MAPKAPK3 (3pK) is a serine/threonine protein kinase that functions as a convergence point of mitogen and stress signaling, being phosphorylated and activated downstream of the ERK, p38, and JNK MAPK cascades (PMID:8943323, PMID:8622688). Through its kinase activity it acts on multiple substrates to regulate chromatin state, autophagy, and apoptosis: it directly phosphorylates the Polycomb group protein Bmi1 and other PcG members, driving their dissociation from chromatin and de-repression of the Cdkn2a/INK4A locus product p14ARF (PMID:15563468), and it phosphorylates the bHLH transcription factor E47 to repress E-box-dependent transcription (PMID:10781029). Together with MAPKAPK2, it promotes starvation-induced autophagy by phosphorylating Beclin 1 at serine 90, an event antagonized by BCL2 (PMID:25693418). It also directly phosphorylates Bax, restraining its mitochondrial translocation and thereby limiting apoptosis (PMID:40976474). A dominant p.Leu173Pro mutation that mislocalizes the protein to the cytoplasm disrupts the cytoskeleton and cytodieresis, and Mapkapk3-knockout mice show Bruch's membrane abnormalities, establishing a role in cell division and RPE/Bruch's membrane integrity (PMID:26744326).

1. 1996 High

   Established 3pK as a bona fide MAPK substrate kinase, placing it downstream of the Raf/MEK/ERK mitogenic cascade.

   Evidence In vitro kinase assays with recombinant ERK plus in vivo serum/TPA stimulation with pathway inhibitors in HL60 and HEK293 cells

   PMID:8622688 PMID:8943323

   Open questions at the time

   • Physiological substrates of activated 3pK not identified at this stage
   • Activation kinetics relative to other MAPKAPKs not defined
2. 1996 High

   Showed 3pK is also activated by p38 and JNK, defining it as the first kinase integrating signals from all three MAPK cascades and a node where mitogen and stress inputs converge.

   Evidence In vitro kinase assays with recombinant p38RK and JNK, co-transfection epistasis, and SB203580 blockade

   PMID:8943323

   Open questions at the time

   • Whether the three cascades activate 3pK in distinct cellular contexts unresolved
   • Downstream consequences of each input not distinguished
3. 2000 Medium

   Identified the first transcriptional substrate of 3pK, linking its kinase activity to repression of E-box-dependent gene expression.

   Evidence In vitro kinase assay, co-immunoprecipitation, and E-box luciferase reporter assay with 3pK overexpression

   PMID:10781029

   Open questions at the time

   • Phosphosite on E47 not mapped
   • Single lab, overexpression-based; endogenous relevance not established
4. 2004 High

   Connected 3pK to epigenetic control by showing it phosphorylates Bmi1/PcG proteins to evict them from chromatin and de-repress the INK4A/p14ARF locus.

   Evidence Yeast two-hybrid, reciprocal Co-IP, in vitro/in vivo phosphorylation, chromatin fractionation, and p14ARF expression analysis

   PMID:15563468

   Open questions at the time

   • Specific Bmi1 phosphosites and their stoichiometry not fully defined
   • Upstream MAPK input driving this event in vivo not identified
5. 2009 Medium

   Linked MAPKAPK3 to negative regulation of type I interferon signaling output.

   Evidence ISRE- and GAS-driven luciferase reporter assays and allele-specific transcript quantification in liver biopsy

   PMID:19208361

   Open questions at the time

   • Direct biochemical substrate in the IFN pathway not defined
   • Effect shown by overexpression; endogenous kinase requirement untested
6. 2015 High

   Defined a direct mechanistic role in autophagy by identifying Beclin 1 S90 as a MK2/MK3 phosphosite required for starvation-induced autophagy and Beclin 1 tumor suppressor function.

   Evidence In vitro kinase assays, Beclin 1 S90 mutagenesis, MK2/MK3 genetic knockout, in vivo autophagy assays, and BCL2 manipulation

   PMID:25693418

   Open questions at the time

   • Relative contributions of MK2 versus MK3 not separated
   • Which MAPK cascade triggers this phosphorylation during starvation unresolved
7. 2016 Medium

   Demonstrated that correct nuclear localization of MAPKAPK3 is required for cell division and tissue integrity, via a mislocalizing dominant mutation and a knockout mouse.

   Evidence p.Leu173Pro mutant localization imaging and cytodieresis assays in HEK cells plus Mapkapk3-/- mouse Bruch's membrane histology

   PMID:26744326

   Open questions at the time

   • Substrates underlying the cytoskeletal/cytodieresis defect not identified
   • Mechanism linking kinase to Bruch's membrane physiology unknown
8. 2020 Low

   Associated 3PK with EZH2 stability and PcG-mediated repression in oral squamous carcinoma cells.

   Evidence Co-IP, ChIP-qPCR, Western blot, and immunofluorescence under pharmacological 3PK inhibition

   PMID:33113500

   Open questions at the time

   • Mechanistic link between 3PK and EZH2 proteasomal degradation not biochemically reconstituted
   • Findings embedded in a drug-treatment study; direct phosphorylation of EZH2 not demonstrated
9. 2025 Medium

   Identified Bax as a direct MAPKAPK3 substrate, positioning the kinase as a brake on intrinsic apoptosis.

   Evidence Co-IP, phosphorylation assay, Bax mitochondrial fractionation, and MAPKAPK3 knockdown apoptosis readouts in neuroblastoma cells

   PMID:40976474

   Open questions at the time

   • Bax phosphosite not mapped
   • Single lab, not yet replicated; reciprocal validation lacking

• How distinct upstream MAPK inputs are routed to specific substrates (chromatin, autophagy, apoptosis) to produce context-specific outputs remains unresolved.
• No unifying model linking activating cascade to substrate choice
• In vivo substrate hierarchy under physiological stress unknown